2
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Uterine Cervical Neoplasms
10
Neoplasms
9
Breast Neoplasms
9
Colorectal Neoplasms
8
Lung Neoplasms
5
Papillomavirus Infections
3
Uterine Cervical Dysplasia
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Heart Diseases
2
HIV Infections
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
End Stage Liver Disease
2
the Rate of Participation in Screening for PBC
1
Warts
1
Venous Thromboembolism
1
Uterine Cervical Diseases
1
Urinary Bladder Neoplasms
1
Tinea
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Skin Neoplasms
1
Retinoblastoma
1
Radiation Injuries
1
Pulmonary Atelectasis
1
Postural Orthostatic Tachycardia Syndrome
1
Postoperative Complications
1
Interventions
apixaban
22
Rivaroxaban
16
Dalteparin
16
Enoxaparin
11
Heparin, Low-Molecular-Weight
10
Tinzaparin
8
Aspirin
8
Fondaparinux
4
Dabigatran
4
edoxaban
3
Warfarin
3
Nadroparin
3
bemiparin
2
abelacimab
2
Rosuvastatin Calcium
2
Observation
2
MAA868
2
sotorasib
1
ribociclib
1
reviparin
1
palbociclib
1
isoquercitrin
1
enoxaparin sodium
1
certoparin
1
calcium heparin
1
betrixaban
1
argatroban
1
acarboxyprothrombin
1
abemaciclib
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Venous Thromboembolism
×
Mass Screening
×
Clear all
NCT01088334
2010-03-29
Trousseau
Slotervaart Hospital
Terminated
630 enrolled